Recombinant multi-species RNF128 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RNF128 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a type I transmembrane protein that localizes to the endocytic pathway. This protein contains a RING zinc-finger motif and has been shown to possess E3 ubiquitin ligase activity. Expression of this gene in retrovirally transduced T cell hybridoma significantly inhibits activation-induced IL2 and IL4 cytokine production. Induced expression of this gene was observed in anergic CD4(+) T cells, which suggested a role in the induction of anergic phenotype. Alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 1300002C13Rik,E3 ubiquitin-protein ligase RNF128,GRAIL,Gene related to anergy in lymphocytes protein (GRAIL),Greul1,RGD1566282,RING finger protein 128,RING-type E3 ubiquitin transferase RNF128,RNF128,Rnf128

Target products collectionGo to RNF128 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP1504-Ag-1/ GM-Tg-hg-IP1504-Ag-2 Human RNF128 protein Human
GM-Tg-rg-IP1504-Ag-1/ GM-Tg-rg-IP1504-Ag-2 Rat RNF128 protein Rat
GM-Tg-mg-IP1504-Ag-1/ GM-Tg-mg-IP1504-Ag-2 Mouse RNF128 protein Mouse
GM-Tg-cynog-IP1504-Ag-1/ GM-Tg-cynog-IP1504-Ag-2 Cynomolgus/Rhesus macaque RNF128 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP1504-Ag-1/ GM-Tg-felg-IP1504-Ag-2 Feline RNF128 protein Feline
GM-Tg-cang-IP1504-Ag-1/ GM-Tg-cang-IP1504-Ag-2 Canine RNF128 protein Canine
GM-Tg-bovg-IP1504-Ag-1/ GM-Tg-bovg-IP1504-Ag-2 Bovine RNF128 protein Bovine
GM-Tg-equg-IP1504-Ag-1/ GM-Tg-equg-IP1504-Ag-2 Equine RNF128 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP1504-Ag-1/ GM-Tg-hg-IP1504-Ag-2; GM-Tg-rg-IP1504-Ag-1/ GM-Tg-rg-IP1504-Ag-2;
GM-Tg-mg-IP1504-Ag-1/ GM-Tg-mg-IP1504-Ag-2; GM-Tg-cynog-IP1504-Ag-1/ GM-Tg-cynog-IP1504-Ag-2;
GM-Tg-felg-IP1504-Ag-1/ GM-Tg-felg-IP1504-Ag-2; GM-Tg-cang-IP1504-Ag-1/ GM-Tg-cang-IP1504-Ag-2;
GM-Tg-bovg-IP1504-Ag-1/ GM-Tg-bovg-IP1504-Ag-2; GM-Tg-equg-IP1504-Ag-1/ GM-Tg-equg-IP1504-Ag-2
Products Name RNF128 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name RNF128
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RNF128 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.